Dr Laetitia Devy-Dimanche
Chief Executive Officer
Laetitia joined AMAL in March 2022 and is now Chief Executive Officer.
Laetitia has more than 17 years of global pharmaceutical industry experience, both in Biotech and Biopharmaceutical companies, with high Drug Development knowledge
applying expertise. She completed a post-doctoral fellowship in Biochemistry and Molecular Biology at U.F.R. Pharmacy Reims, France, and held senior strategic positions within the industry since then.